Sunil Iyengar

22PUBLICATIONS
111CO-AUTHORS
Molecular medicineHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

|Apr 14, 2026
Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Clive S Zent, Enrico Tiacci, Robert J Kreitman

|Mar 08, 2026
Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival.

Maeve A O'Reilly, William Wilson, Bernard Maybury

|Aug 14, 2025
Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study.

Alex F Herrera, Stephen M Ansell, Pier Luigi Zinzani

|Oct 13, 2023
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.

Pietro R Di Ciaccio, Mark N Polizzotto, Kate Cwynarski

|Feb 01, 2023
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma.

Claire Roddie, Lorna Neill, Wendy Osborne

Pageof 4

Frequent Collaborators

5 joint publications

Dima El-Sharkawi

5 joint publications

Pier Luigi Zinzani

4 joint publications

Francesco Forconi

4 joint publications

Toby A Eyre